SPTBN2 促进免疫抑制性肿瘤微环境及对抗癌治疗的交叉耐药
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.
Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。